Stoke Therapeutics STOK
NASDAQ STOK
$25.57 -0.44 (-1.69%)
As of: Oct 2, 2026 · 2:18 PM EDT

Stoke Therapeutics (STOK) Shares Outstanding (Diluted) (2021 - 2026)

Updated

Stoke Therapeutics' Shares Outstanding (Diluted) came in at 66.02 million for Q2 2026, up 13.1% from 58.35 million a year earlier and up 4.7% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

For FY2025, Stoke Therapeutics' Shares Outstanding (Diluted) was 59.22 million, up 9.6% from FY2024.

  • Shares Outstanding (Diluted) has increased in each of the last four years, with a four-year compound annual growth rate of 12.7% (FY2021 to FY2025).
  • Going back by year, Shares Outstanding (Diluted) was 54.01 million in FY2024 (+22.8%), 43.99 million in FY2023 (+13.1%), 38.9 million in FY2022 (+5.9%) and 36.74 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2021.
  • Year-over-year, Shares Outstanding (Diluted) has increased for 17 consecutive quarters, with growth averaging 14.5% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Diluted) has ranged between 4.0% (Q3 2025) and 28.4% (Q1 2025) over the last five years.
  • Business Quant data shows STOK's Shares Outstanding (Diluted) at 63.06 million (Q1 2026), 59.22 million (Q4 2025) and 58.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 66.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.02 Mn
Mar 31, 2026 63.06 Mn
Dec 31, 2025 59.22 Mn
Sep 30, 2025 58.61 Mn
Jun 30, 2025 58.35 Mn
Mar 31, 2025 59.40 Mn
Dec 31, 2024 54.01 Mn
Sep 30, 2024 56.34 Mn
Jun 30, 2024 55.77 Mn
Mar 31, 2024 46.25 Mn
Dec 31, 2023 43.99 Mn
Sep 30, 2023 44.27 Mn
Jun 30, 2023 44.19 Mn
Mar 31, 2023 42.54 Mn
Dec 31, 2022 38.90 Mn
Sep 30, 2022 39.26 Mn
Jun 30, 2022 39.26 Mn
Mar 31, 2022 37.45 Mn
Dec 31, 2021 36.74 Mn
Sep 30, 2021 36.71 Mn
API Access

Stoke Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=STOK&period=max&api_key=YOUR_API_KEY